Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure

Journal of the American College of Cardiology

Volumn 33, Issue 7, 1999, Pages 1848-1854

  Senior, Roxy ^a   Kaul, Sanjiv ^b   Lahiri, Avijit ^b  

^a Northwick Pk St Mark's H ^*  (United Kingdom)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; CIRCADIAN RHYTHM; CORONARY ANGIOGRAPHY; DOBUTAMINE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032720716     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00102-3     Document Type: Article

References (33)

1. Gheorghiade M., Bonow R.O. Chronic heart failure in the United States. A manifestation of coronary artery disease. Circulation. 97:1998;282-289.
2. Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994;72 Suppl 3-9.
3. Passamani E., Davis K.B., Gillespie M.J., Killip T. A randomized trial of coronary artery bypass surgery survival of patients with a low ejection fraction . N Engl J Med. 312:1985;1665-1671.
4. Varnauskas E. Twelve year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med. 319:1988;332-337.
5. Di Carli M.F., Asgarzadie F., Schelbert H.R., et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 92:1995;3436-3444.
6. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary artery bypass surgery in patients with severely depressed left ventricular function. Circulation. 87:1993;1630-1641.
7. Pagley P.R., Beller G.A., Watson D.D., et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 96:1997;793-800.
8. Weiner D.A., Ryan T.J., McCabe C.H., et al. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol. 3:1984;772-779.
9. Weiner D.A., McCabe C.H., Ryan T.J. Identification of patients with left main and three vessel coronary disease with clinical and exercise test variables. Am J Cardiol. 46:1980;21-27.
10. Kaul S. The response of the dysfunctional myocardium to dobutamine: "The Eyes See What the Mind Knows!" J Am Coll Cardiol. 27:1996;1608-1611.
11. Sklenar J., Camarano G., Goodman N.C., et al. Contractile versus microvascular reserve for the determination of the extent of myocardial salvage after reperfusion the effect of residual stenosis . Circulation. 94:1996;1430-1440.
12. Pierard L.A., de Landsheere C.M., Berthe C., et al. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy comparison with positron emission tomography . J Am Coll Cardiol. 15:1990;1021-1031.
13. Smart S.C., Sawada S.C., Ryan T., et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation. 88:1993;405-415.
14. Senior R., Glenville B., Basu S., et al. Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularization in severe ischaemic left ventricular dysfunction. Br Heart J. 74:1995;358-364.
15. Vanoverschelde J.-L.J., D'Hondt A.M., Marwick T., et al. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol. 28:1996;432-442.
16. La Canna G., Alfieri O., Giubbibi R., et al. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 23:1994;617-626.
17. Cigarroa C.C., deFillipi C.R., Brickner E., et al. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation. 88:1993;430-436.
18. Kaul S. There may be more to myocardial viability than meets the eye! Circulation. 92:1995;2790-2793.
19. Senior R., Sridhara B.S., Basu S., et al. Comparison of radionuclide ventriculography and 2D echocardiography for the measurement of left ventricular ejection fraction following acute myocardial infarction. Eur Heart J. 15:1994;1235-1239.
20. Touchstone D.A., Nygaard T.W., Kaul S. Correlation between left ventricular risk area and clinical, electrocardiographic, hemodynamic, and angiographic variables during acute myocardial infarction. J Am Soc Echocardiogr. 3:1990;106-117.
21. Dash H., Johnson R.A., Dinsmore R.E., Hawthorne J.W. Cardiomyopathic syndrome due to coronary artery disease. I. Relation to angiographic extent of coronary artery disease and to remote myocardial infarction. Br Heart J. 39:1997;733-739.
22. Cox D. Regression models and life tables (with discussion). JR Stat Soc B. 34:1972;187-220.
23. Fletcher R.H., Fletcher S.W., Wagner E.H. Clinical Epidemiology. The Essentials. 2nd ed. 1988;Williams and Wilkins, Baltimore (MD).
24. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assn. 53:1958;457-481.
25. Alderman E.L., Fisher L.D., Litwin P., et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 68:1983;785-795.
26. Pigott J.D., Kouchoukos N.T., Oberman A., Cutter G.R. Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol. 5:1985;1036-1045.
27. Firoozan S, Wei K, Linka A, et al. A canine model of chronic ischemic cardiomyopathy: characterization of regional flow-function relations. Am J Physiol 1999;276:446-55.
28. Dargie H.J., McMurray J.J.V. Diagnosis and management of heart failure. Br Med J. 308:1994;321-328.
29. Rahimtoola S.H., Grunkemeier G.L., Starr A. Ten-year survival after coronary artery bypass surgery for angina in patients 65 years and older. Circulation. 74:1988;509-517.
30. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med. 334:1996;1349-1355.
31. Williams M.J., Odabashian J., Lauer M.S., et al. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol. 27:1996;132-139.
32. Afridi I., Grayburn P.A., Panza J.A., et al. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol. 32:1998;921-926.
33. Meluzin J., Cerny J., Frelich M., et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 32:1998;912-920.